ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults
Top Cited Papers
- 17 November 2011
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 365 (20), 1896-1904
- https://doi.org/10.1056/nejmoa1110212
Abstract
Adverse-event reports from North America have raised concern that the use of drugs for attention deficit–hyperactivity disorder (ADHD) increases the risk of serious cardiovascular events. We conducted a retrospective cohort study with automated data from four health plans (Tennessee Medicaid, Washington State Medicaid, Kaiser Permanente California, and OptumInsight Epidemiology), with 1,200,438 children and young adults between the ages of 2 and 24 years and 2,579,104 person-years of follow-up, including 373,667 person-years of current use of ADHD drugs. We identified serious cardiovascular events (sudden cardiac death, acute myocardial infarction, and stroke) from health-plan data and vital records, with end points validated by medical-record review. We estimated the relative risk of end points among current users, as compared with nonusers, with hazard ratios from Cox regression models. Cohort members had 81 serious cardiovascular events (3.1 per 100,000 person-years). Current users of ADHD drugs were not at increased risk for serious cardiovascular events (adjusted hazard ratio, 0.75; 95% confidence interval [CI], 0.31 to 1.85). Risk was not increased for any of the individual end points, or for current users as compared with former users (adjusted hazard ratio, 0.70; 95% CI, 0.29 to 1.72). Alternative analyses addressing several study assumptions also showed no significant association between the use of an ADHD drug and the risk of a study end point. This large study showed no evidence that current use of an ADHD drug was associated with an increased risk of serious cardiovascular events, although the upper limit of the 95% confidence interval indicated that a doubling of the risk could not be ruled out. However, the absolute magnitude of such an increased risk would be low. (Funded by the Agency for Healthcare Research and Quality and the Food and Drug Administration.)Keywords
This publication has 39 references indexed in Scilit:
- Cardiovascular Events and Death in Children Exposed and Unexposed to ADHD AgentsPublished by American Academy of Pediatrics (AAP) ,2011
- A computer case definition for sudden cardiac deathPharmacoepidemiology and Drug Safety, 2009
- Mortality Associated with Attention-Deficit Hyperactivity Disorder (ADHD) Drug TreatmentDrug Safety, 2009
- Cardiac Safety of Methylphenidate Versus Amphetamine Salts in the Treatment of ADHDPublished by American Academy of Pediatrics (AAP) ,2009
- Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the LiteratureJournal of the American Academy of Child & Adolescent Psychiatry, 2008
- An alternative approach to age adjustment of cancer survival ratesEuropean Journal Of Cancer, 2004
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial InfarctionJournal of the American College of Cardiology, 2004
- International diagnostic criteria for acute myocardial infarction and acute strokeAmerican Heart Journal, 1984
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983
- Clinical classification of cardiac deaths.Circulation, 1982